Triggers for Acceptance of COVID-19 Vaccination: A Community- Based Study

Author:

Abd-Elsalam Sherief1,Medhat Mohammed A.2,Nour Mohamed O.34,Yousef Ahmed5,El-Raey Fathiya6,Aly Heba7,Mousa Sherief8,Makhlouf Nahed A2,El Badry Mohamed9,Baki Amin Abdel10,Saeed Maysaa A.11,Hassan Esssam A.12,Shaltout Shaker Wagih13,Fathelbab Hanaa Kh.14,Zaky Samy15

Affiliation:

1. Tropical Medicine and Infectious Diseases Department, Faculty of Medicine, Tanta University, Tanta, Egypt

2. Tropical Medicine and Gastroenterology Department, Assiut University, Assiut, Egypt

3. Department of Public Health and Community Medicine, Damietta Faculty of Medicine, Al-Azhar University, Damietta, Egypt

4. Faculty of Public Health and Health Informatics, Umm Al-Qura University, Makkah, KSA

5. Department of Public Health and Community Medicine, Damietta Faculty of Medicine, Al-Azhar University, Damietta, Egypt

6. Hepatogastroenterology and Infectious Diseases Department, Al-Azhar University, Damietta, Egypt

7. Tropical Medicine Department, Faculty of Medicine, Ain Shams University, Cairo, Egypt

8. Endemic Medicine Department, Faculty of Medicine, Cairo University, Cairo, Egypt

9. Endemic Medicine Department, Helwan University, Cairo, Egypt

10. Hepatology, Gastroenterology and Infectious Diseases, National Hepatology and Tropical Medicine Research Institute (NHTMRI), Cairo, Egypt

11. Tropical Medicine Department, Faculty of Medicine, Zagazig University, Zagazig, Egypt

12. Tropical Medicine Department, Fayoum University, Faiyum Egypt

13. Tropical Medicine Department, Faculty of Medicine, Port Said University, Portsaid Egypt

14. Endemic Diseases Department, Minia University, Minia, Egypt

15. Hepatogastroenterology and Infectious Diseases Department, Al-Azhar University, Cairo, Egypt

Abstract

Background: COVID- 19 vaccines have been released, giving a major hope of getting rid of the dark pandemic crisis. The availability of vaccines does not necessarily mean that the mass vaccination program is a success. We aimed to investigate COVID-19 vaccination knowledge level, acceptance rate, and perception state among Egyptians. Methods: An analytical cross-sectional online survey was carried out utilizing a selfadministered adult questionnaire that assesses vaccination acceptance with related sociodemographic factors and perceptions based on health belief model perspectives. Predictors of vaccination acceptance were based on logistic regression analysis. Results: We analyzed data for 957 participants, aged 18–78 years, 55.7% were females, and 66.9% were healthcare workers (HCWs). About one-fourth had a history of confirmed COVID-19 infection and 56.5% would accept to have one of the COVID-19 vaccines, where “Pfizer” was the preferable one (37.8%), while “AstraZeneca” was the most rejected vaccine (26.8%). The 1st vaccine dose was received by 273 (28.5%) of which 260 were intended to receive the 2nd dose. Vaccine efficacy, side effects, protection time, and administration route were essentially among the factors that may influence their decision to accept COVID-19 vaccines. About 83.1% had good knowledge about vaccination which was significantly higher with increased age, among graduates/professionals, governmental workers, HCWs in addition to those able to save/invest money, had a history of confirmed COVID-19 infection and intending to have COVID-19 vaccine. Perceptions that vaccination decreases the chance of getting COVID-19 or its complications (OR = 9.28; CI: 5.03-17.12), vaccination makes less worry about catching COVID-19 (OR = 6.76; CI: 3.88-11.76), and being afraid of getting COVID-19 (OR = 2.04; CI: 1.26–3.31) were strong significant predictors for vaccine acceptance. Conclusions: Vaccine campaigns should emphasize vaccine benefits and highlight the severity of infection while addressing barriers to vaccination in order to improve vaccine coverage among populations.

Publisher

Bentham Science Publishers Ltd.

Subject

Pharmacology (medical),Infectious Diseases,Drug Discovery

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3